Share-based Payment Arrangement, Expense of Editas Medicine, Inc. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Editas Medicine, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • Editas Medicine, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2,228,000, a 54% decline year-over-year.
  • Editas Medicine, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $11,891,000, a 48% decline year-over-year.
  • Editas Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $21,417,000, a 8.2% increase from 2023.
  • Editas Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $19,798,000, a 32% decline from 2022.
  • Editas Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $29,294,000, a 33% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Editas Medicine, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $11,891,000 $2,228,000 -$2,574,000 -54% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $14,465,000 $2,664,000 -$2,346,000 -47% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $16,811,000 $2,979,000 -$4,606,000 -61% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $21,417,000 $4,020,000 -$1,325,000 -25% 01 Oct 2024 31 Dec 2024 10-K 05 Mar 2025 2024 FY
Q3 2024 $22,742,000 $4,802,000 +$71,000 +1.5% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 $22,671,000 $5,010,000 -$205,000 -3.9% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $22,876,000 $7,585,000 +$3,078,000 +68% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 $19,798,000 $5,345,000 -$19,000 -0.35% 01 Oct 2023 31 Dec 2023 10-K 05 Mar 2025 2024 FY
Q3 2023 $19,817,000 $4,731,000 -$1,150,000 -20% 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024 2024 Q3
Q2 2023 $20,967,000 $5,215,000 -$1,403,000 -21% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $22,370,000 $4,507,000 -$6,924,000 -61% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 $29,294,000 $5,364,000 -$2,293,000 -30% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $31,587,000 $5,881,000 -$4,131,000 -41% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023 2023 Q3
Q2 2022 $35,718,000 $6,618,000 -$6,908,000 -51% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q1 2022 $42,626,000 $11,431,000 -$773,000 -6.3% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q4 2021 $43,399,000 $7,657,000 +$1,984,000 +35% 01 Oct 2021 31 Dec 2021 10-K 22 Feb 2023 2022 FY
Q3 2021 $41,415,000 $10,012,000 +$4,166,000 +71% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 $37,249,000 $13,526,000 +$8,109,000 +150% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 $29,140,000 $12,204,000 +$5,984,000 +96% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 $23,156,000 $5,673,000 -$663,000 -10% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $23,819,000 $5,846,000 -$713,000 -11% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $24,532,000 $5,417,000 -$1,076,000 -17% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $25,608,000 $6,220,000 -$1,635,000 -21% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q4 2019 $27,243,000 $6,336,000 -$11,000 -0.17% 01 Oct 2019 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 $27,254,000 $6,559,000 -$140,000 -2.1% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020 2020 Q3
Q2 2019 $27,394,000 $6,493,000 -$531,000 -7.6% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020 2020 Q2
Q1 2019 $27,925,000 $7,855,000 +$1,327,000 +20% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q4 2018 $26,598,000 $6,347,000 -$1,739,000 -22% 01 Oct 2018 31 Dec 2018 10-K 26 Feb 2020 2019 FY
Q3 2018 $28,337,000 $6,699,000 +$2,231,000 +50% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $26,106,000 $7,024,000 +$2,008,000 +40% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 $24,098,000 $6,528,000 +$724,000 +12% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q4 2017 $23,374,000 $8,086,000 +$4,303,000 +114% 01 Oct 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
Q3 2017 $19,071,000 $4,468,000 +$777,000 +21% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018 2018 Q3
Q2 2017 $18,294,000 $5,016,000 -$181,000 -3.5% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018 2018 Q2
Q1 2017 $18,475,000 $5,804,000 +$1,594,000 +38% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018 2018 Q1
Q4 2016 $16,881,000 $3,783,000 +$1,832,000 +94% 01 Oct 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
Q3 2016 $15,049,000 $3,691,000 +$2,634,000 +249% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017 2017 Q3
Q2 2016 $12,415,000 $5,197,000 +$4,757,000 +1081% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2017 Q2
Q1 2016 $7,658,000 $4,210,000 +$4,145,000 +6377% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q4 2015 $3,513,000 $1,951,000 01 Oct 2015 31 Dec 2015 10-K 08 Mar 2018 2017 FY
Q3 2015 $1,057,000 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3
Q2 2015 $440,000 01 Apr 2015 30 Jun 2015 10-Q 10 Aug 2016 2016 Q2
Q1 2015 $65,000 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016 2016 Q1

Editas Medicine, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $21,417,000 +$1,619,000 +8.2% 01 Jan 2024 31 Dec 2024 10-K 05 Mar 2025 2024 FY
2023 $19,798,000 -$9,496,000 -32% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2025 2024 FY
2022 $29,294,000 -$14,105,000 -33% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2024 2023 FY
2021 $43,399,000 +$20,243,000 +87% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2023 2022 FY
2020 $23,156,000 -$4,087,000 -15% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2022 2021 FY
2019 $27,243,000 +$645,000 +2.4% 01 Jan 2019 31 Dec 2019 10-K 26 Feb 2021 2020 FY
2018 $26,598,000 +$3,224,000 +14% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2020 2019 FY
2017 $23,374,000 +$6,493,000 +38% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020 2019 FY
2016 $16,881,000 +$13,368,000 +381% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
2015 $3,513,000 +$3,458,000 +6287% 01 Jan 2015 31 Dec 2015 10-K 08 Mar 2018 2017 FY
2014 $55,000 01 Jan 2014 31 Dec 2014 10-K 03 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.